Richard Jagger is the CEO of a company called Bio-Gene Technology, which listed in October 2017 in a $7 million IPO. They’re in the pesticide business so Alan Kohler gave Richard a call to find out more about the company.
Alan Kohler is one of Australia’s most respected finance reporters. For decades readers and viewers have enjoyed his expert opinion in press, television and of course on line. His writing and interviews bring a context to the issues that matter to investors, with a personality that is often missing from other financial experts. Alan started The Constant Investor to be able to directly share his passion for discovering exciting companies.